19 publications
Name | Date | Type | Actions |
---|---|---|---|
2011 annual earnings Lure (France), April 03, 2012 – The Vétoquinol Board Meeting of March 26, 2012 has reviewed the Group’s business and approved the 2011 financial statements. |
03/04/2012 | Public releases | |
2011, a year of transition Lure (France), January 24, 2012 – In 2011, Vétoquinol achieved sales of €284.1 million, 0.7% up on the previous year and stable on a like-for-like basis. |
24/01/2012 | Public releases | |
2017 sales: €352.2 million 7.6% like-for-like growth in essentials products The Vetoquinol Group posted sales of €352.2 million for the 2017 financial year, up 1.0% like-forlike. After a negative currency impact of 0.5%, mainly linked to the US and Canadian dollars, reported growth amounted to 0.5%. |
23/01/2018 | Public releases | |
Combined ordinary and extraordinary general meeting May 29, 2018 The Combined Ordinary and Extraordinary General meeting was held on Tuesday May 29, 2018 in Lure, chaired by Etienne Frechin. |
29/05/2018 | Public releases | |
First half 2018 results At its meeting on July 25, 2018, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the audited first half 2018 financial statements. |
26/07/2018 | Public releases | |
Flevox® the new parasiticide for dogs and cats Lure (France), 14 February 2012 – Vétoquinol launches Flevox®, the latest addition to its range of parasiticides. The new drug is based on fipronil, the molecule par excellence in the treatment of tick and flea infestations in pets. |
14/02/2012 | Public releases | |
Forcyl® - a booming brand Lure (France), November 14, 2012 – Vétoquinol receives a new indication for its Forcyl® product, designed for cattle, and a new market authorization for Forcyl® Swine for pigs. |
14/11/2012 | Public releases | |
Q1 2018 sales: €87.6M like-for-like growth up 5.6%, 0.4% as reported growth of essentials products: up 6.8% as reported Vetoquinol posted Q1 2018 consolidated sales of €87.6 million, up 5.6% like for like and 0.4% as reported, compared to the same period last year. Negative currency impacts of 5.2% were mainly related to the US and Canadian dollars and the Indian rupee. |
12/04/2018 | Public releases | |
Q3 2018 sales: €90.2 million Vetoquinol wins second prize for CSR in the Gaia Rating In the first nine months of 2018, Vetoquinol recorded sales of €268.1 million, up 3.8% at constant exchange rates and 0.4% as reported. |
18/10/2018 | Public releases | |
Sales momentum continues in Q3 Vétoquinol posted sales of €220.9 million for the first 9 months of 2012, up 6.2% compared to the same period last year. |
25/10/2012 | Public releases |